Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.
Medicare GLP-1 Bridge $245 Net Price: What It Means for Your $50 Copay
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
The short answer, before you scroll
The Medicare GLP-1 Bridge $245 net price is not what you pay at the pharmacy. If you qualify, you pay a $50 copay for a month’s supply. The $245 is the deal between the government and the drugmakers — a behind-the-scenes number you never hand over.
The Medicare GLP-1 Bridge $245 net price is not what you pay at the pharmacy. If you qualify, you pay a $50 copay for a month’s supply. The $245 is the deal price between the government and the drugmakers — a behind-the-scenes number you never hand over. So if you saw a headline screaming “$245” and your stomach dropped, take a breath. For eligible Medicare members, the number that hits your wallet is $50.
But here’s the part the headlines skip, and it’s the reason this page exists: that $50 comes with three catches that can quietly cost you later. It doesn’t count toward your Part D out-of-pocket cap. Extra Help won’t lower it. And the program only covers certain drugs, for certain reasons, for people in certain plans. Get one of those wrong and your prescription can land in the wrong lane — or get denied.
We read the actual rules from CMS — the federal agency that runs Medicare — so you don’t have to. Below is the plain-English breakdown of who pays what, why two prices keep showing up, and the exact questions to ask your doctor and pharmacist before July 1, 2026.
Which number is actually yours?
| Number you saw | What it really is | Is it your cost? |
|---|---|---|
| $50 | The copay an eligible member pays at the pharmacy counter | Yes — if you’re approved for the Bridge |
| $245 | The net price drugmakers agreed to give the government per month | No — you never pay this directly |
| Hundreds to $1,000+ | Cash or list prices outside the Bridge, depending on the drug and formulation | No — not for an eligible, approved Bridge fill |
Want to know if you meet the Bridge rules?
Read the full Medicare GLP-1 Bridge eligibility guide →Plain-English checklist — the BMI rules, the plan types, and the prior authorization steps, all in one place.
Is the Medicare GLP-1 Bridge $245 net price what I pay?
Think of it like this. When you buy something on sale, you see the sale price — not the secret wholesale deal the store struck with the supplier. The $50 is your sale price. The $245 is the supplier deal. Both are real. Only one is yours.
This comes straight from CMS. The Bridge is a short-term pilot program that runs July 1, 2026 through December 31, 2027. During that window, eligible members can fill a covered GLP-1 prescription for $50 a month — no matter the dose, and no matter where you are in your Part D year.
That last part surprises people, so it’s worth saying plainly: the $50 stays $50. Whether it’s January or November, whether you’ve hit your deductible or not, the copay doesn’t move. So the short answer to the number that’s been stressing everyone out: $245 is not your cost. $50 is.
Why am I seeing both $245 and $50 for Medicare GLP-1s?
Here’s the money flow, step by step. We mapped this out because CMS and policy groups like KFF explain these pieces in scattered, technical paragraphs — nobody hands it to you as one simple path.
- 1
You → Pharmacy
You hand over your $50 copay and pick up your medicine.
- 2
Pharmacy → Central processor
The pharmacy sends the claim to a central processor (SS&C Health, via RelayHealth), not to your regular Part D plan.
- 3
Central processor → Pharmacy
The pharmacy gets paid back based on the drug's wholesale acquisition cost, minus your $50, plus a dispensing fee and any sales tax.
- 4
Drugmaker → Government
The manufacturer then pays money back to the government so the whole thing nets out to $245 per monthly supply. That's the number you never see.
Two important rules from CMS: The Bridge is the primary payer for these prescriptions and does not coordinate with your other coverage. Coupons and discount cards can’t be stacked on top of a Bridge claim. If you were planning to layer a manufacturer savings card on the $50, that won’t work. The $50 is the floor and the ceiling.
Does the $50 Medicare GLP-1 Bridge copay count toward your Part D out-of-pocket cap?
The Bridge runs outside your normal Part D benefit. CMS confirms two things that matter to your yearly budget:
- No part of the $50 copay counts toward your TrOOP — your “true out-of-pocket” total, the running tally that gets you to your Part D cap.
- No part of the $245 net price counts toward your gross covered drug costs either.
In 2026, the Part D out-of-pocket cap is $2,100 (rising to $2,400 in 2027), according to KFF. Once you hit that cap, your other covered drugs cost you nothing for the rest of the year. Normally, every dollar you spend at the pharmacy chips away at that cap. Bridge fills don’t.
| Time period | Bridge copay you pay | Counted toward Part D cap | What it means |
|---|---|---|---|
| July–December 2026 (6 fills) | $300 | $0 | Six months of Bridge fills don’t move you toward the 2026 cap |
| Full-year 2027 (12 fills) | $600 | $0 | A whole year of Bridge fills still counts for nothing toward the cap |
| If you get Extra Help / LIS | $50 per fill | $0 | The low-income subsidy does not lower the $50 |
The reassuring part: For the typical person who just wants affordable access to Wegovy, Zepbound, or Foundayo, the Bridge is one of the best deals on the table right now. $50/month for a brand-name GLP-1 is dramatically cheaper than current cash and list prices, which run from the hundreds into the low four figures. You just want to walk in knowing the cap won’t budge.
BMI tiers, plan types, prior authorization steps — all in one place.
Who qualifies for the $50 Medicare GLP-1 Bridge copay?
Here’s the short version so you know whether to keep reading. For the full rules, see our dedicated eligibility guide.
Eligible plan type
A standalone Part D drug plan (PDP) or a Medicare Advantage plan with drug coverage (MA-PD). Special Needs Plans, employer/union group plans, and LI NET also count. PACE, private fee-for-service, and certain cost plans generally don’t qualify on their own. The Bridge is nationwide — available in every state and territory.
One of three clinical lanes (measured at therapy initiation, not today)
- ✓BMI 35 or higher — on its own, or
- ✓BMI 30 or higher plus heart failure with preserved ejection fraction, uncontrolled high blood pressure (above 140/90 despite two BP medicines), or CKD stage 3a or worse, or
- ✓BMI 27 or higher plus prediabetes, a past heart attack, a past stroke, or symptomatic peripheral artery disease.
Already on a GLP-1 and lost weight?
CMS measures the BMI criterion at the time you started GLP-1 therapy, not today. If you began in 2024 at a BMI of 37 and you’re now at 34, your provider can attest to the BMI at therapy initiation. Losing weight on the drug doesn’t disqualify you. Bring historical weight records.
BMI tiers, plan types, prior authorization steps — all in one place.
Which GLP-1 drugs are covered by the Medicare GLP-1 Bridge?
Drug name alone isn’t enough here — the formulation matters, and this trips people up. Here’s the current list, confirmed on the CMS Bridge page:
| Drug / formulation | Bridge status | Note |
|---|---|---|
| Foundayo (all formulations) | ✅ Covered | An oral GLP-1 pill; FDA-approved April 2026 and added to the Bridge list April 6, 2026 |
| Wegovy injection | ✅ Covered | All formulations |
| Wegovy tablets | ✅ Covered | All formulations |
| Zepbound KwikPen | ✅ Covered | KwikPen only — this is the critical distinction |
| Zepbound single-dose vial | ❌ Not covered | Not a Bridge formulation |
| Zepbound single-dose pen | ❌ Not covered | Not a Bridge formulation |
| Ozempic, Mounjaro, Rybelsus | ❌ Not on Bridge weight-loss list | These follow regular Part D rules for approved uses like type 2 diabetes |
If your prescription is for a Zepbound vial or single-dose pen: ask your prescriber whether the KwikPen version is right for you — it’s the only Zepbound formulation the Bridge covers. CMS publishes the specific NDC codes for covered products, and notes the list may update over the life of the program.
Medicare GLP-1 Bridge vs regular Part D: which lane is yours?
This is the most useful thing we can give you, because picking the wrong lane is how prescriptions get denied or delayed. CMS is clear: if your GLP-1 is prescribed for a use that’s already coverable under regular Part D, it does not go through the Bridge. Two examples CMS gives directly: Zepbound for moderate-to-severe sleep apnea in adults with obesity, and Wegovy to lower heart-attack and stroke risk in adults with heart disease and excess weight.
| Why your GLP-1 was prescribed | Your likely lane | Why |
|---|---|---|
| To lose weight and keep it off | Medicare GLP-1 Bridge (if eligible) | The Bridge exists specifically for eligible weight-management use |
| Type 2 diabetes | Regular Part D | Diabetes use follows your plan's normal coverage |
| Heart-attack / stroke risk reduction | Regular Part D | CMS lists this as a regular Part D-covered use |
| Sleep apnea with obesity | Regular Part D | CMS lists this as a regular Part D-covered use |
| You have Medicaid | State Medicaid rules / BALANCE Model | Handled by your state, not the Medicare Bridge |
| No Part D coverage at all | Not the Bridge | The Bridge requires an eligible Part D plan |
Here’s why the lane matters in practice. If your doctor sends a prior authorization to your regular Part D plan for a weight-loss prescription the plan doesn’t cover, it can bounce. CMS is encouraging plans to redirect those cases to the Bridge’s central processor instead — but the system is brand new, so it pays to get the routing right the first time.
Genuinely unsure whether your prescription is a Bridge claim or a regular Part D claim? Check the eligibility rules before your doctor submits the paperwork →
What happened to the BALANCE Model, and does it change the $245 price?
CMS announced two things in December 2025: the BALANCE Model (a longer-term plan for covering obesity drugs in Medicare and Medicaid) and the Bridge (a short-term pilot to provide access while BALANCE got going). BALANCE was meant to take over in Medicare Part D in 2027. But by the spring 2026 deadline, not enough Part D plans had agreed to participate — so CMS stretched the Bridge out to run July 1, 2026 through December 31, 2027.
| When | What happens |
|---|---|
| July 1, 2026 | Medicare GLP-1 Bridge starts |
| 2027 | BALANCE does not launch in Medicare Part D as originally planned |
| December 31, 2027 | Current Bridge end date |
| 2028 and beyond | Uncertain — depends on whether CMS restarts BALANCE or creates another path |
KFF has flagged the open question of how members keep affordable obesity coverage after the Bridge ends if no permanent program is in place. That’s not a reason to skip the $50 deal now — it’s a reason to keep an eye on the calendar and revisit your options as 2027 closes.
What should I ask my doctor and pharmacist?
Say this to your doctor:
“Based on my diagnosis, my BMI when I started this medicine, the exact drug and formulation, and my plan type — should this prescription go through the Medicare GLP-1 Bridge, or through my regular Part D plan?”
Say this to your pharmacist (starting July 1):
“If this is a Bridge prescription, it should be processed through the Bridge’s central processor, not my regular Part D plan. Can you confirm the claim is going to the right place?”
If your pharmacist needs the technical routing details, CMS published a Bridge payer sheet with everything they need. You don’t have to understand this part — it’s for them — but having it on hand can save a confusing trip to the counter:
| Payer-sheet field (for your pharmacist) | Value |
|---|---|
| Payer name | CMS Medicare Part D |
| Plan / group | GLP1Bridge |
| BIN | 028918 |
| PCN | MEDDGLP1BR |
| Processor | SS&C Health |
| Claim routing | RelayHealth |
| Effective date | July 1, 2026 |
| Cardholder ID | The beneficiary's MBI, as shown on the Medicare card |
| Pharmacy/provider help desk | 844-673-0910 (for pharmacies and prescribers — not a beneficiary line) |
| Paper claims / direct member reimbursement | Not accepted |
| Compounded drugs | Not allowed |
Bring-to-your-visit checklist:
- →Your Medicare card and your Part D or MA-PD plan card
- →The drug and formulation your provider is considering (remember: Zepbound KwikPen, not the vial)
- →Your height/weight and BMI when you started the GLP-1
- →Documentation of any qualifying condition (heart, kidney, blood pressure, prediabetes, prior heart attack or stroke)
- →Your prior GLP-1 fill history if you're already on one
- →A note to ask whether the prior authorization goes to the Bridge processor or your plan
What if I don’t qualify for the $50 Bridge route?
Your prescription is for diabetes, heart risk, or sleep apnea
Good news — that's not a dead end, it's a different door. Those uses are often coverable under your regular Part D plan. Ask your prescriber to pursue your plan's normal coverage or its formulary-exception process.
Your prescription is for a Zepbound vial or single-dose pen
Only the KwikPen is on the Bridge list. Ask your provider whether the KwikPen works for you.
You have Medicaid, not Medicare
Medicaid coverage of GLP-1s runs through your state's rules and the Medicaid side of the BALANCE Model, which is rolling out state by state. Your path depends on where you live.
You're not on Medicare at all
If you landed here and you're not a Medicare member — or you're helping a family member who isn't eligible — then the Bridge isn't your program, and neither is regular Part D. Manufacturer savings cards and telehealth programs are generally your main options.
A word of caution: manufacturer savings cards and telehealth “insurance help” generally do not apply to Medicare, Medicaid, or other government coverage. If you are a Medicare member, the $50 Bridge route is almost always cheaper than paying cash. Cash-pay only makes sense if you’re genuinely outside every government route.
Already confirmed the Bridge and regular Part D aren’t for you — or you’re not on Medicare?
Compare your other GLP-1 options →Disclosure: The RX Index may earn a commission if you choose certain provider links after using our quiz. Our Medicare Bridge information on this page is based on CMS and KFF sources, not on commissions.
Ro Body (sponsored affiliate link, opens in a new tab) (cash-pay path) — Pairs you with a licensed physician for clinical oversight and access to FDA-approved Foundayo, Wegovy, and Zepbound. Ro cannot coordinate Medicare medication coverage, but is a legitimate self-pay option for people outside every government route.
Ro Body: $39 for the first month, then as low as $74/month with annual plan (or $149/month). Medication billed separately. This is a cash-pay path, not a Medicare Bridge application path.
Check pricing on Ro → (sponsored affiliate link, opens in a new tab)Disclosure: The RX Index may earn a commission. Ro is a cash-pay path and is not a Medicare GLP-1 Bridge application path.
How we verified the Medicare GLP-1 Bridge $245 net price
A page about your money and your medicine should show its work. Here’s exactly what we checked against primary sources, and what’s still pending.
| Claim | Source | Verified |
|---|---|---|
| Bridge runs July 1, 2026 – Dec 31, 2027 | CMS Bridge page | ✓ May 28, 2026 |
| $245 net price; $50 copay | CMS Bridge page; KFF | ✓ May 28, 2026 |
| $50 doesn't count toward TrOOP; $245 doesn't count toward gross covered drug costs | CMS Bridge page | ✓ May 28, 2026 |
| Extra Help / low-income subsidy doesn't reduce the $50 | CMS Bridge page | ✓ May 28, 2026 |
| Covered drugs: Foundayo, Wegovy (injection + tablets), Zepbound KwikPen | CMS Bridge page | ✓ May 28, 2026 |
| Zepbound vial and single-dose pen excluded | CMS Bridge page | ✓ May 28, 2026 |
| Clinical BMI lanes and qualifying conditions | CMS Bridge page | ✓ May 28, 2026 |
| 2026 Part D cap $2,100; 2027 cap $2,400 | KFF | ✓ May 28, 2026 |
| Bridge extended because BALANCE didn't launch for 2027 | CMS Bridge page; KFF | ✓ May 28, 2026 |
| Pharmacy routing: BIN 028918, PCN MEDDGLP1BR, processor SS&C Health, RelayHealth routing, help desk 844-673-0910, MBI as cardholder ID, effective July 1, 2026 | CMS GLP-1 Bridge payer sheet (dated March 16, 2026) | ✓ May 28, 2026 |
| Compounded drugs not allowed; coupons/discounts can't be applied | CMS Bridge page; CMS payer sheet | ✓ May 28, 2026 |
What’s still operationally pending:
- →The full, consumer-facing prior authorization workflow. CMS has published pharmacy claims routing details, but its Bridge page says additional PA guidance is coming.
- →Exactly how each pharmacy's system will handle Bridge claims at launch.
- →Whether every prescriber's office will know how to route Bridge prior authorizations on day one.
- →What coverage looks like after December 31, 2027.
Because pieces of this program are still being finalized, we re-check the CMS sources regularly and update the verified date at the top. If you’re reading this close to or after July 1, 2026, confirm any operational detail with your plan or the CMS Bridge page before acting.
Frequently asked questions
Is the Medicare GLP-1 Bridge $245 net price my monthly cost?
No. The $245 is the program's behind-the-scenes net price between drugmakers and the government. If you're eligible and approved, you pay a $50 copay per monthly supply at the pharmacy.
Why does CMS mention $245 if I pay $50?
Because the two numbers describe different parts of the same transaction. You pay the pharmacy $50. The pharmacy is reimbursed through a central processor, and the drugmaker pays money back to the government so the program nets out to $245 per month. Only the $50 touches you.
Does the $50 copay count toward my Part D out-of-pocket maximum?
No. CMS confirms the $50 copay does not count toward your true out-of-pocket total (TrOOP), and the $245 net price does not count toward your gross covered drug costs. The Bridge runs outside your normal Part D benefit.
Does Extra Help lower the $50 Bridge copay?
No. Low-income cost-sharing subsidies do not apply to any part of the Bridge copay. Even if you normally pay very low copays, you'd owe the full $50 for a Bridge fill.
Which drugs are covered by the Bridge?
For weight management, CMS currently covers Foundayo, Wegovy (injection and tablets), and the Zepbound KwikPen. The Zepbound single-dose vial and single-dose pen are not covered. The list can change during the program.
Is Ozempic or Mounjaro covered by the Bridge?
Not on the Bridge weight-loss list. Those drugs follow regular Part D rules for their approved uses, such as type 2 diabetes. The Bridge list is focused on weight-management products.
Do compounded semaglutide or tirzepatide qualify for the Medicare GLP-1 Bridge?
No. The Bridge covers only the specific FDA-approved products and drug codes (NDCs) that CMS lists, and the CMS payer sheet states that compounded drugs are not allowed. Compounded GLP-1s cannot be billed through the Bridge.
What BIN and PCN does the Medicare GLP-1 Bridge use?
CMS lists BIN 028918 and PCN MEDDGLP1BR for Bridge claims. The CMS payer sheet also names SS&C Health as the processor, with claims routed through RelayHealth, an effective date of July 1, 2026, and a pharmacy/provider help desk at 844-673-0910. These details are for your pharmacist.
Does my Part D plan have to opt in?
No. The Bridge operates outside the Part D payment flow, and plan sponsors don't have to opt in for eligible members to use it starting July 1, 2026.
Who submits the prior authorization?
A medical provider submits the prior authorization request and the prescription for a covered drug. The provider doesn't have to be enrolled in Medicare, but they can't be on the CMS Preclusion List.
Can I use a manufacturer coupon or discount card with the Bridge?
No. CMS states coupons and discount programs may not be applied to Bridge claims. The Bridge is the primary payer and doesn't coordinate with other coverage.
What happens after December 31, 2027?
The Bridge is currently set to end then. Long-term Medicare obesity-drug coverage after that date is uncertain unless CMS implements BALANCE in Part D or another pathway. Watch for updates as 2027 closes.
Can a telehealth company get me the $50 Medicare Bridge price?
Only if the prescribing provider and the pharmacy claim meet the Bridge's requirements through Medicare's process. Many telehealth and cash-pay programs state they can't coordinate coverage for government insurance. If you're a Medicare member, the $50 Bridge route is usually the cheaper path anyway.
The bottom line
If you saw “$245” and panicked, you can relax: that’s not your price. Eligible Medicare members pay $50 a month for Wegovy, Zepbound (KwikPen), or Foundayo through the GLP-1 Bridge starting July 1, 2026. Just remember the three catches — the $50 doesn’t build toward your Part D cap, Extra Help won’t lower it, and only certain drugs and reasons qualify. Confirm your lane with your doctor, confirm the claim routing with your pharmacy, and you’re set.
The single best move you can make today is to walk into your next appointment knowing exactly what to ask. Bring the checklist above, ask which lane your prescription belongs in, and you’ve done the hard part.
BMI tiers, plan types, prior authorization steps — all in one place.
Sources
- →Centers for Medicare & Medicaid Services (CMS), Medicare GLP-1 Bridge — official FAQ page
- →CMS, GLP-1 Bridge Pharmacy Payer Sheet (dated March 16, 2026)
- →CMS, BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model
- →KFF, What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid (2026)
Related guides: Medicare GLP-1 Bridge eligibility · CMS BALANCE Model eligibility · Does Medicare cover Wegovy? · Does Medicare cover Zepbound? · Does Medicare cover Foundayo?
This article is general information about a Medicare program and is not medical, financial, or insurance advice. Coverage rules can change. Confirm eligibility, drug coverage, and costs with your plan, your prescriber, or Medicare (1-800-MEDICARE / 1-800-633-4227) before making decisions. against the CMS Medicare GLP-1 Bridge page, the CMS GLP-1 Bridge pharmacy payer sheet dated March 16, 2026, KFF policy analysis, and manufacturer access pages.